share_log

HC Wainwright & Co. Reiterates Buy on Solid Biosciences, Maintains $16 Price Target

HC Wainwright & Co. Reiterates Buy on Solid Biosciences, Maintains $16 Price Target

HC Wainwright & Co.重申買入Solid Biosciences,維持16美元的目標股價
Moomoo 24/7 ·  03/14 07:30

HC Wainwright & Co. analyst Arthur He reiterates Solid Biosciences (NASDAQ:SLDB) with a Buy and maintains $16 price target.

HC Wainwright & Co. 分析師亞瑟·何重申了Solid Biosciences(納斯達克股票代碼:SLDB)的買入並維持16美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論